Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana'a city, Yemen: first report on prevalence and predictors.
Kwkab A R Al-BrhamiRashad Abdul-GhaniSalah A Al-QobatiPublished in: BMC infectious diseases (2022)
The prevalence of intestinal microsporidiosis among HIV/AIDS patients in Sana'a is high and comparable to that reported from several other countries, being prevalent among approximately 14.0% of patients and significantly associated with diarrhea. It could be predicted among patients who have < 200 CD4 cells/µl, have poor hand hygiene after contacting soil and before eating, usually eat unwashed raw produce, or do not possess indoor latrines. Large-scale studies on its epidemiology and predictors among HIV/AIDS patients across the country are warranted.
Keyphrases
- hiv aids
- antiretroviral therapy
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- human immunodeficiency virus
- hiv infected
- risk factors
- prognostic factors
- physical activity
- air pollution
- hiv infected patients
- signaling pathway
- induced apoptosis
- risk assessment
- cell death
- south africa
- hepatitis c virus
- heavy metals
- cell proliferation
- oral health
- irritable bowel syndrome